SOPHiA GENETICS Email Format
Biotechnology ResearchVaud, Switzerland501-1000 Employees
Founded in 2011 by biologists, SOPHiA GENETICS operates in the biotechnology research field with a platform designed to turn complex data into clinically actionable insights. The system uses artificial intelligence to learn from genomic and multimodal data contributed by a broad user community, creating collective intelligence over time and supporting diagnostics and treatment decisions for cancer and rare inherited disorders. This data-driven approach aims to expand access to precision medicine and improve patient care globally. Based in Rolle, Vaud, Switzerland, the company serves clinicians, researchers, and biopharma developers seeking data-driven decision support. In 2026, SOPHiA GENETICS announced a collaboration with MD Anderson Cancer Center to develop AI-driven precision oncology tools, including an advanced sequencing test.